Five-Year Outcomes of a Personalized Pro Re Nata Treatment Regimen With Anti-Vascular Endothelial Growth Factor for Neovascular Age-Related Macular Degeneration

Acta Ophthalmologica - United States
doi 10.1111/aos.13840
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Outcomes When Switching From a Pro Re Nata Regimen to a Treat and Extend Regimen Using Aflibercept in Neovascular Age-Related Macular Degeneration

Ophthalmologica
MedicineOphthalmologySensory Systems
2016English

Vascular Endothelial Growth Factor Inhibitors in the Treatment of Neovascular Age-Related Macular Degeneration

Vestnik Oftalmologii
MedicineOphthalmology
2017English

Characterisation of Poor Visual Outcomes of Neovascular Age-Related Macular Degeneration Treated With Anti-Vascular Endothelial Growth Factor Agents

Ophthalmology
Ophthalmology
2019English

Vitreomacular Traction Affects Anti-Vascular Endothelial Growth Factor Treatment Outcomes for Exudative Age-Related Macular Degeneration

Retina
MedicineOphthalmology
2015English

An 8-Year Follow-Up of Anti-Vascular Endothelial Growth Factor Treatment With a Treat-And-Extend Modality for Neovascular Age-Related Macular Degeneration

Acta Ophthalmologica
MedicineOphthalmology
2017English

Simulating an Anti–Vascular Endothelial Growth Factor Switch in Neovascular Age-Related Macular Degeneration: A HARBOR Subanalysis

Ophthalmology
Ophthalmology
2019English

One-Year Outcomes of 1 Dose Versus 3 Loading Doses Followed by Pro Re Nata Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration: The ARTIS Trial

Journal of Ophthalmology
Ophthalmology
2019English

Does Genetic Variation Influence Response to Treatment With Vascular Endothelial Growth Factor Inhibitors in Neovascular Age-Related Macular Degeneration?

Ophthalmic Epidemiology
EpidemiologyOphthalmology
2014English

Intravitreal Injection of Ranibizumab Using A pro Re Nata Regimen for Age-Related Macular Degeneration and Vision-Related Quality of Life

Clinical Ophthalmology
Ophthalmology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy